VIR Competitors & Alternatives
Compare Vir Biotechnology Inc with similar stocks in the same industry
Biotechnology
VIR
Main Stock$10.04
Tradestie Score
57
Market Cap
$791.82M
Revenue Growth
4.2%
Analyst Upside
+114.7%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLDX
Celldex Therapeutics, Inc
|
$38.37
|
$1.68B | - | 57 | Compare |
|
MNKD
Mannkind Corporation
|
$4.52
|
$1.65B | - | 66 | Compare |
|
MPLT
MPLT
|
$37.09
|
$1.63B | - | 53 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$39.56
|
$1.63B | - | 58 | Compare |
|
BHVN
Biohaven Ltd.
|
$15.96
|
$1.57B | - | 57 | Compare |
|
VCEL
Vericel Corporation
|
$46.98
|
$1.56B | 105.0 | 59 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$94.34
|
$1.55B | - | 57 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$37.26
|
$1.55B | 14.5 | 65 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$33.86
|
$1.55B | - | 61 | Compare |
|
NVAX
Novavax Inc
|
$9.74
|
$1.54B | - | 54 | Compare |
More VIR Analysis
Data updated: Jul 03, 2026 | Industry: Biotechnology (SIC 2836)
235 stocks in this industry